VIVANTA PHARMACEUTICALS PRIVATE LIMITED
VIVANTA PHARMACEUTICALS PRIVATE LIMITED is a Punjab based PRIVATE LIMITED company, Registered at dated 23-MAY-2012 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of VIVANTA PHARMACEUTICALS PRIVATE LIMITED is U24232CH2012PTC033822 and registration number is 033822.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies CHANDIGARH India. Authorized share capital of VIVANTA PHARMACEUTICALS PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 0 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 0.
VIVANTA PHARMACEUTICALS PRIVATE LIMITED has 2 directors DEEPAK JAIN, TARUN SACHDEVA,
The registered Email address of VIVANTA PHARMACEUTICALS PRIVATE LIMITED is tarunk6@rediffmail.com and its registered address is 306, 2ND-FLOOR, SECTOR 32A, CHANDIGARH CHANDIGARH INDIA 160047 Punjab Punjab india 160047.
The current status of VIVANTA PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
VIVANTA PHARMACEUTICALS PRIVATE LIMITED
CHANDIGARH
ACTIVE
METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING
U24232CH2012PTC033822
23 MAY 2012
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
160047
INDIA
306, 2ND-FLOOR, SECTOR 32A, CHANDIGARH CHANDIGARH INDIA 160047
tarunk6@rediffmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
02935839 | DEEPAK JAIN | Director | 23/05/2012 |
05278406 | TARUN SACHDEVA | Director | 23/05/2012 |
Details Updated by Companies
Quick Links
- All Registered company of Punjab
- Company Registered in Punjab
- All Registered company of CHANDIGHAR in Punjab
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.